Cytodyn Inc (CYDY)

Currency in USD
0.2368
+0.0069(+3.00%)
Closed·
CYDY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.22700.2427
52 wk Range
0.18290.3970
Key Statistics
Prev. Close
0.2368
Open
0.227
Day's Range
0.227-0.2427
52 wk Range
0.1829-0.397
Volume
1.59M
Average Volume (3m)
1.83M
1-Year Change
-5.0902%
Book Value / Share
-0.071
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYDY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Cytodyn Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
Oct 28, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CYDY Income Statement

Compare CYDY to Peers and Sector

Metrics to compare
CYDY
Peers
Sector
Relationship
P/E Ratio
−5.9x−2.7x−0.2x
PEG Ratio
0.04−0.040.00
Price/Book
−3.5x2.2x2.6x
Price / LTM Sales
-122.7x2.8x
Upside (Analyst Target)
-148.9%60.9%
Fair Value Upside
Unlock16.4%9.5%Unlock

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. The company develops leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. Its leronlimab completed phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
147.48K0.01%33.89K
Public Companies & Retail Investors
1.47B99.99%337.52M
Total
1.47B100.00%337.56M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Diversified Trust Company, Inc.0.00%45,79011
Williams Jones Wealth Management, LLC0.00%45,00110

People Also Watch

0.0005
ADTX
-28.57%
0.1100
SGMOQ
-3.51%
8.395
PBYI
+1.76%
1.100
MBOT
-0.90%
15.860
XERS
+4.34%

FAQ

What Is the Cytodyn Inc (CYDY) Stock Price Today?

The Cytodyn Inc stock price today is 0.2368 USD.

What Stock Exchange Does Cytodyn Inc Trade On?

Cytodyn Inc is listed and trades on the OTC Markets.

What Is the Stock Symbol for Cytodyn Inc?

The stock symbol for Cytodyn Inc is "CYDY."

What Is the Cytodyn Inc Market Cap?

As of today, Cytodyn Inc market cap is 347.9100M USD.

What Is Cytodyn Inc's Earnings Per Share (TTM)?

The Cytodyn Inc EPS (TTM) is -0.044.

When Is the Next Cytodyn Inc Earnings Date?

Cytodyn Inc will release its next earnings report on Feb 03, 2027.

From a Technical Analysis Perspective, Is CYDY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Cytodyn Inc Stock Split?

Cytodyn Inc has split 0 times.

How Many Employees Does Cytodyn Inc Have?

Cytodyn Inc has 14 employees.

What is the current trading status of Cytodyn Inc (CYDY)?

As of Nov 10, 2026, Cytodyn Inc (CYDY) is trading at a price of 0.2368 USD, with a previous close of 0.2368 USD. The stock has fluctuated within a day range of 0.2270 USD to 0.2427 USD, while its 52-week range spans from 0.1829 USD to 0.3970 USD.

What Is the CYDY After Hours Price?

CYDY's last after hours stock price is 0.2506 USD, the stock has decreased by 0.0005, or 0.1800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.